Inventor · disambiguated record
Stephen P. Squinto
Also filed as: SQUINTO STEPHEN · SQUINTO STEPHEN P
24 granted patents·14 pending applications·1,150 citations·filing 1990–2023
97Inventor score
Top patents by PatentIndex Score
38 records- 0196US6355245B1C5-specific antibodies for the treatment of inflammatory diseasesALEXION PHARMA INC·Filed 1995·Granted Mar 12, 2002·465 cites·23 claims
- 0294US9447176B2Methods and compositions for treating complement-associated disordersROTHER RUSSELL P·Filed 2009·Granted Sep 20, 2016·21 cites·4 claims
- 0393US9771418B2Methods for treating complement-associated disordersALEXION PHARMA INC·Filed 2016·Granted Sep 26, 2017·8 cites·4 claims
- 0492US6338820B1Apparatus for performing assays at reaction sitesALEXION PHARMA INC·Filed 1998·Granted Jan 15, 2002·96 cites·52 claims
- 0587US5847082ATerminal complement inhibitor fusion proteinsALEXION PHARMA INC·Filed 1995·Granted Dec 8, 1998·60 cites·4 claims
- 0685US5624837ANucleic acid encoding chimeric complement inhibitor proteinsALEXION PHARMA INC·Filed 1995·Granted Apr 29, 1997·62 cites·8 claims
- 0785US5169764AMultitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimerasREGENERON PHARMA·Filed 1990·Granted Dec 8, 1992·64 cites·34 claims
- 0881US6916654B1Universal donor cellsUNIV YALE·Filed 2000·Granted Jul 12, 2005·22 cites·13 claims
- 0980US5627264AChimeric complement inhibitor proteinsALEXION PHARMA INC·Filed 1994·Granted May 6, 1997·54 cites·5 claims
- 1078US6100443AUniversal donor cellsOKLAHOMA MED RES FOUND·Filed 1995·Granted Aug 8, 2000·31 cites·17 claims
- 1175US6905657B2Methods and devices for storing and dispensing liquidsBIOPROCESSORS CORP·Filed 2001·Granted Jun 14, 2005·9 cites·20 claims
- 1274US5643770ARetroviral vector particles expressing complement inhibitor activityALEXION PHARMA INC·Filed 1994·Granted Jul 1, 1997·39 cites·17 claims
- 1370US5871997AMethods and compositions for protecting retroviral vector particles and producer cells from inactivation by complement via reduction of the expression or recognition of galactose alpha (1,3) galactosyl epitopesALEXION PHARMA INC·Filed 1995·Granted Feb 16, 1999·19 cites·11 claims
- 1470US5705732AUniversal donor cellsOKLAHOMA MED RES FOUND·Filed 1993·Granted Jan 6, 1998·24 cites·5 claims
- 1570US2020140531A1Methods for treating complement-associated disordersALEXION PHARMA INC·Filed 2019·Application pending·0 cites
- 1667US5512661AMultitrophic and multifunctional chimeric neurotrophic factorsREGENERON PHARMA·Filed 1994·Granted Apr 30, 1996·23 cites·32 claims
- 1765US2025170259A1Compositions and methods for delivering therapeutic polynucleotides for exon skippingUNIV YALE·Filed 2023·Application pending·0 cites
- 1865US2017369562A1Methods for treating complement-associated disordersALEXION PHARMA INC·Filed 2017·Application pending·0 cites
- 1963US5648334AMethods of treatment using ciliary neurotrophic factorREGENERON PHARMA·Filed 1995·Granted Jul 15, 1997·16 cites·4 claims
- 2063US2023303719A1Humanized 3e10 antibodies, variants, and antigen binding fragments thereofUNIV YALE·Filed 2023·Application pending·0 cites
- 2162US2025161484A1Compositions and methods for treating diseaseUNIV YALE·Filed 2023·Application pending·0 cites
- 2262US2017015740A1Methods for treating complement-associated disordersALEXION PHARMA INC·Filed 2016·Application pending·0 cites
- 2361US2016319004A1Methods and compositions for treating complement-associated disordersALEXION PHARMA INC·Filed 2016·Application pending·0 cites
- 2459US2024181086A1Compositions and methods for delivering therapeutic polynucleotidesUNIV YALE·Filed 2022·Application pending·0 cites
- 2559US2024216530A1Compositions and Methods for Treating Skeletal Muscle DiseaseUNIV YALE·Filed 2022·Application pending·0 cites
- 2658US5622862AAssay systems for trkB neurotrophin activityREGENERON PHARMA·Filed 1994·Granted Apr 22, 1997·14 cites·1 claims
- 2758US5426177ACiliary neurotrophic factor receptorREGENERON PHARMA·Filed 1991·Granted Jun 20, 1995·23 cites·1 claims
- 2857US2024190998A1Compositions and methods for delivery of nucleic acids to cellsUNIV YALE·Filed 2021·Application pending·0 cites
- 2954US5853722AUse of C5-specific antibodies for reducing immune and hemostatic dysfunctions during extracorporeal circulationALEXION PHARMA INC·Filed 1995·Granted Dec 29, 1998·73 cites·8 claims
- 3053US5849897ANucleic acid molecule encoding ciliary neurotrophic factor receptorREGENERON PHARMA·Filed 1995·Granted Dec 15, 1998·6 cites·10 claims
- 3151US5562904ARetroviral transduction of cells using soluble complement inhibitorsALEXION PHARMA INC·Filed 1994·Granted Oct 8, 1996·14 cites·5 claims
- 3247US2005118074A1Methods and devices for storing and dispensing liquidsBIOPROCESSORS CORP·Filed 2004·Application pending·0 cites
- 3346US5892003ACiliary neurotrophic factor receptor antibodiesREGENERON PHARMA·Filed 1996·Granted Apr 6, 1999·5 cites·1 claims
- 3445US2007041972A1Antibodies and fusion proteins that include engineered constant regionsALEXION PHARMA INC·Filed 2004·Application pending·0 cites
- 3543US2018289612A1CosmeceuticalKEPREA LLC·Filed 2016·Application pending·0 cites
- 3637US6316206B1Method for screening comprising cells expressing the CNTF receptorREGENERON PHARMA·Filed 1998·Granted Nov 13, 2001·2 cites·1 claims
- 3729US2002045247A1Methods for the preparation of retroviral particles and cell lines deficient in the alpha-galactosyl epitopeFiled 1995·Application pending·0 cites
- 3826US7041503B2Modified myelin basic protein moleculesALEXION PHARMA INC·Filed 1995·Granted May 9, 2006·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Stephen P. Squinto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →